Company: TeraImmune, Inc.
Job title: CEO & Founder
Scalable Manufacturing of Engineered Treg cells for Vein-to-Vein Processes 12:00 pm
• Maintaining function while consistently producing disease-specific Treg cells • Providing stability and viability while freezing to allow for adequate storing and timely administration • Assessing stability of phenotype profiles to prevent T cell reversion and ensure safety when transplanting back into the patientRead more
day: Day Two | Track A | Morning